Specific distinguishing features associated with anti-Caspr2 antibodies included a variety of symptoms such as hyponatremia, neuropathy, encephalopathy, hallucinations, and epilepsy, while no distinctive features were reported for anti-CV2/CRMP5 and anti-Homer-3 antibodies. Here, DPYSL5 is linked to epilepsy.